- Home
- ULH vs EYPT Comparison
ULH vs EYPT Comparison
Compare ULH & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULH
- EYPT
- Stock Information
- Founded
- ULH 1932
- EYPT 1987
- Country
- ULH United States
- EYPT United States
- Employees
- ULH N/A
- EYPT N/A
- Industry
- ULH Trucking Freight/Courier Services
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- ULH Industrials
- EYPT Industrials
- Exchange
- ULH Nasdaq
- EYPT Nasdaq
- Market Cap
- ULH 635.2M
- EYPT 579.4M
- IPO Year
- ULH 2005
- EYPT 2005
- Fundamental
- Price
- ULH $23.34
- EYPT $10.06
- Analyst Decision
- ULH Hold
- EYPT Strong Buy
- Analyst Count
- ULH 1
- EYPT 8
- Target Price
- ULH $29.00
- EYPT $24.75
- AVG Volume (30 Days)
- ULH 57.6K
- EYPT 624.2K
- Earning Date
- ULH 07-24-2025
- EYPT 08-06-2025
- Dividend Yield
- ULH 1.85%
- EYPT N/A
- EPS Growth
- ULH N/A
- EYPT N/A
- EPS
- ULH 2.31
- EYPT N/A
- Revenue
- ULH $1,668,148,000.00
- EYPT $56,042,000.00
- Revenue This Year
- ULH N/A
- EYPT N/A
- Revenue Next Year
- ULH $7.88
- EYPT N/A
- P/E Ratio
- ULH $10.02
- EYPT N/A
- Revenue Growth
- ULH N/A
- EYPT 12.04
- 52 Week Low
- ULH $20.60
- EYPT $3.91
- 52 Week High
- ULH $53.29
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- ULH 38.21
- EYPT 53.38
- Support Level
- ULH $24.92
- EYPT $9.77
- Resistance Level
- ULH $30.76
- EYPT $10.41
- Average True Range (ATR)
- ULH 1.67
- EYPT 0.52
- MACD
- ULH -0.53
- EYPT -0.15
- Stochastic Oscillator
- ULH 0.00
- EYPT 38.34
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.